SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 325 filers reported holding SEATTLE GENETICS INC in Q2 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $52,266,000 | +11.2% | 267,087 | -3.5% | 0.04% | 0.0% |
| Q2 2020 | $47,022,000 | +21.6% | 276,729 | -17.4% | 0.04% | +2.9% |
| Q1 2020 | $38,667,000 | +13.8% | 335,128 | +12.7% | 0.04% | +59.1% |
| Q4 2019 | $33,983,000 | +104.1% | 297,448 | +52.5% | 0.02% | +83.3% |
| Q3 2019 | $16,651,000 | +80.0% | 195,024 | +45.8% | 0.01% | +140.0% |
| Q2 2019 | $9,252,000 | +26.2% | 133,729 | +33.5% | 0.01% | +25.0% |
| Q1 2019 | $7,334,000 | +66.0% | 100,188 | +28.5% | 0.00% | +33.3% |
| Q4 2018 | $4,417,000 | -75.9% | 77,996 | -67.1% | 0.00% | -40.0% |
| Q3 2018 | $18,302,000 | -67.2% | 237,349 | -71.8% | 0.01% | -68.8% |
| Q2 2018 | $55,857,000 | +60.0% | 841,385 | +26.1% | 0.02% | -5.9% |
| Q1 2018 | $34,912,000 | +94.3% | 667,102 | +98.5% | 0.02% | +41.7% |
| Q4 2017 | $17,971,000 | -62.1% | 335,989 | -61.5% | 0.01% | -62.5% |
| Q3 2017 | $47,430,000 | +14.3% | 871,816 | +8.7% | 0.03% | +6.7% |
| Q2 2017 | $41,491,000 | -21.3% | 802,048 | -4.3% | 0.03% | -23.1% |
| Q1 2017 | $52,705,000 | +17.0% | 838,508 | -1.8% | 0.04% | +8.3% |
| Q4 2016 | $45,044,000 | -14.0% | 853,710 | -11.9% | 0.04% | -2.7% |
| Q3 2016 | $52,348,000 | +33.5% | 969,314 | -0.1% | 0.04% | +32.1% |
| Q2 2016 | $39,223,000 | +42.9% | 970,683 | +24.1% | 0.03% | +33.3% |
| Q1 2016 | $27,456,000 | -10.4% | 782,468 | +14.6% | 0.02% | 0.0% |
| Q4 2015 | $30,645,000 | -22.6% | 682,906 | -33.5% | 0.02% | -32.3% |
| Q3 2015 | $39,571,000 | -3.7% | 1,026,324 | +20.9% | 0.03% | +19.2% |
| Q2 2015 | $41,098,000 | +100.4% | 849,192 | +46.4% | 0.03% | +100.0% |
| Q1 2015 | $20,508,000 | -7.4% | 580,221 | -15.8% | 0.01% | -7.1% |
| Q4 2014 | $22,144,000 | -13.4% | 689,291 | +0.2% | 0.01% | -12.5% |
| Q3 2014 | $25,568,000 | -26.2% | 687,764 | -24.1% | 0.02% | -33.3% |
| Q2 2014 | $34,668,000 | -7.6% | 906,446 | +9.9% | 0.02% | -11.1% |
| Q1 2014 | $37,525,000 | +33.1% | 824,872 | +16.7% | 0.03% | +35.0% |
| Q4 2013 | $28,200,000 | +1.1% | 707,011 | +11.1% | 0.02% | -4.8% |
| Q3 2013 | $27,881,000 | – | 636,159 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |